Nautilus Biotechnology, Inc.

Developing a proteomics platform for single-molecule analysis to advance life sciences research.

NAUT | NDAQ

Overview

Corporate Details

ISIN(s):: US63909J1088
LEI:
Country:: United States of America
Address:: 2701 EASTLAKE AVE EAST, 98102 SEATTLE
Website:: https://www.nautilus.bio/
Sector:: Mining and quarrying
Industry:: Mining of non-ferrous metal ores

Description

Nautilus Biotechnology, Inc. is a development-stage life sciences company focused on revolutionizing the field of proteomics. The company is creating a platform to analyze and quantify the human proteome with single-molecule resolution at a massive scale. Its proprietary technology leverages a method called Iterative Mapping to provide high-resolution views of billions of individual protein molecules and their modified forms (proteoforms). Nautilus aims to democratize proteomics by offering an integrated system with accessible workflows and cloud-based analysis tools. The platform is designed to accelerate breakthroughs in drug discovery, biomarker identification, and fundamental biological research by providing clearer insights into the mechanisms of health and disease.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.

Quick Filters:

Filters

Filing Type

Language

Start date

End date

Clear

Bulk Actions:

	Date	Filing	Language	Size	Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all Nautilus Biotechnology, Inc. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Nautilus Biotechnology, Inc.

This data is available as part of our premium data solutions. Contact our team for access.

Request This Data

Need More History? Access decades of standardized financials for Nautilus Biotechnology, Inc. via our API.

Get Historical Data →

Insider Transactions

Date	Insider Name	Position	Type	Shares	Value
No insider transactions recorded for this company.

Peer Companies

Company	Country	Ticker
Medrx Co.,Ltd. Develops and licenses transdermal drug delivery systems for the pharmaceutical industry.	Japan	4586
MegaPro Biomedical Co. Ltd. Developing nanomedicines and drug delivery systems for oncology, hematology, and diagnostics.	Malaysia	N/A
Meiho Holdings,Inc. A holding company driving regional growth by supporting construction, HR, and nursing care businesses.	Japan	7369
Mendus Developing immunotherapies using dendritic cells to prevent cancer recurrence and improve survival.	Sweden	IMMU
Metavista3D, Inc. Develops AI-driven, glasses-free 3D holographic displays for the defense sector.	United States of America	M3D
MicroAd,Inc. Data-driven marketing tech providing DSP and SSP solutions for digital advertising.	Japan	9553
Microwave Chemical Co., Ltd. Innovating chemical and metal processing with an eco-friendly microwave platform.	Japan	9227
MindWalk Holdings Corp. AI-powered biotherapeutics firm offering end-to-end antibody discovery and engineering services.	United States of America	HYFT
Minerva Neurosciences, Inc. A clinical-stage biopharma developing treatments for central nervous system (CNS) diseases.	United States of America	NERV
Mitsubishi Research Institute, Inc. A think tank providing research, consulting, and ICT solutions to public & private sectors.	Japan	3636